Chylomicrons induce E-selectin and VCAM-1 expression in endothelial cells

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue SUPPL. 2, 1997, Pages 35-37

  Moers, A ^a,b   Fenselau, S ^a   Schrezenmeir, J ^a  

^a Federal Research Center   (Germany)

^b Federal Research Centre   (Germany)

Author keywords

Adhesion molecules; Chylomicrons; Lipoprotein lipase

Indexed keywords

CELL ADHESION MOLECULE; CHYLOMICRON; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FOOD INTAKE; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE ADHERENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0030777317     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211793     Document Type: Article

References (19)

1. Cambien F, Jacqueson A, Richard JL, Warnet, JM, Ducimetiere P, Claude, JR: Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterinemic" subjects? The Paris Prospective Sudy. Am. J. Epidemiol. 124, 624-632, 1986
2. Castelli WP: The triglyceride issue: A view from Framingham. Am. Heart J. 112, 432-437, 1986
3. Chung BH, Segrest JP, Smith K, Griffin FM, Brouillette CG: Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. J. Clin. Invest. 83, 1363-137, 1989
4. Cybulsky MI, Gimbrone MAJ: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788-791, 1991
5. Frostegård J, Haegerstrand H, Gidlund M, Nilsson J: Biologically modified LDL increases the adhesive properties of endothelial cells. Atherosclerosis 90, 119-126, 1991
6. Hennig B, Chung BH, Watkins BA, Alvarado A: Disruption of endothelial barrier function by lipolytic remnants of triglyceride-rich lipoproteins. Atherosclerosis 95, 235-247, 1992
7. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52, 2745-2756, 1973
8. Khan BV, Parthasarathy SS, Alexander RW, Medford RM: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest 95, 1262-1270, 1995
9. Kume NM, Cybulsky MI, Gimbrone MA: Lysophosphatidyl-choline, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90, 1138-1144, 1992
10. O' Brien K, Allen M, Mc Donald T, Chait A, Harlan J, Fishbein J, Mc Carty J, Ferguson M, Hudkins K, Benjamin C et al.: Vascular cell adhesion molecule-1 is expressed in human atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 92, 945-951, 1993
11. Poston R N, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey R: Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 140, 665-673, 1992
12. Saxena U, Kulkarni NM, Ferguson E, Newton RS: Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells. Biochem. Biophys. Res. Comm. 189, 1653-1658, 1992
13. Schrezenmeir J, Keppler I, Fenselau S, Weber P, Biesalski HK, Probst R, Laue C, Zuchhold HD, Prellwitz W, Beyer J: The phenomenon of a high triglyceride response to an oral lipid load in healthy subjects and its link to the metabolic syndrome. Ann. NY Acad. Sci. 683, 302-314, 1993
14. Schrezenmeir, J., Weber, P., Probst, R., Biesalski, H. K., Luley, C., Prellwitz, W., Krause, U., Beyer, J.: Postprandial pattern of triglyceride-rich lipoprotein in normal-weight humans after an oral lipid load: exaggerated triglycerides and altered insulin response in some subjects. Ann. Nutr. Metab. 36, 186-196, 1992
15. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J, Roy P: Chylomicrons and chylomicron remnants in coronary artery disease: a case-control study. Atherosclerosis 65, 181-189, 1987
16. Simpson HS, Williamson C M, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard C J, Sheperd J: Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 85, 193-202, 1990
17. Speidel MT, Booyse FM, Abrams A, Moore MA, Chung BH: Lipolyzed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoproteins inhibit this cytotoxicity. Thromb. Res. 58, 251-258, 1990
18. Tollin L, Griesson M, Johnson O, Backman L, Jackobsson KA, Ostermann G, Billström A: Decreased removal of triglycerides from the blood: A mechanism for the hypertriglyceridemia in male patients with coronary artery disease. Int. J. Cardiol. 5, 185-192, 1984
19. Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 60, 473-485, 1979